Your browser doesn't support javascript.
loading
Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial.
Aziz, Faisal; Tripolt, Norbert J; Pferschy, Peter N; Kolesnik, Ewald; Mangge, Harald; Curcic, Pero; Hermann, Markus; Meinitzer, Andreas; von Lewinski, Dirk; Sourij, Harald.
Affiliation
  • Aziz F; Interdisciplinary Metabolic Medicine Trials Unit, Graz, Austria.
  • Tripolt NJ; Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Pferschy PN; Interdisciplinary Metabolic Medicine Trials Unit, Graz, Austria.
  • Kolesnik E; Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Mangge H; Interdisciplinary Metabolic Medicine Trials Unit, Graz, Austria.
  • Curcic P; Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Hermann M; Division of Cardiology, Medical University of Graz, Graz, Austria.
  • Meinitzer A; Clinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • von Lewinski D; Clinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Sourij H; Clinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
Cardiovasc Diabetol ; 22(1): 184, 2023 07 20.
Article in En | MEDLINE | ID: mdl-37475009

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cardiovasc Diabetol Journal subject: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication: